Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Asthma | R-HSA-444620 | map05310 | amphotericin B | 5335 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | amphotericin B | 5335 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | amphotericin B | 5335 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | amphotericin B | 5335 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | amphotericin B | 5335 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | methoxsalen | 4114 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | methoxsalen | 4114 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | methoxsalen | 4114 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | phenazopyridine | 30323 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | phenazopyridine | 30323 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | phenazopyridine | 30323 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | phenazopyridine | 30323 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | phenazopyridine | 30323 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | phenazopyridine | 30323 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | phenazopyridine | 30323 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | phenazopyridine | 30323 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | phenazopyridine | 30323 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | phenazopyridine | 30323 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | phenazopyridine | 30323 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | phenazopyridine | 30323 | drug-path |